SCHEMBL21609024

SCHEMBL21609024

COc1ccc(Cn2c(=O)cnc3cc(C(C)=O)ccc32)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE1B Q01064 1/20 0.50
HPGD P15428 3/20 0.47
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALOX15 P16050 1/20 0.47
HTT P42858 1/20 0.47
CYP1A2 P05177 3/20 0.46
CYP3A4 P08684 3/20 0.46
TSHR P16473 3/20 0.46
USP2 O75604 2/20 0.46
CYP2C9 P11712 2/20 0.46
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HIF1A Q16665 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
PDE5A O76074 1/20 0.44
GSK3B P49841 1/20 0.44
CNR2 P34972 1/20 0.44
TBXA2R P21731 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21608846 0.82 PIK3R1 (0.51) PDE1BHPGDALDH1A1KDM4EALOX15
SCHEMBL13350 0.81 TBXA2R (0.54) TSHRMAPK1CNR2TBXA2RNPC1
SCHEMBL7225918 0.79 MEN1 (0.70) HPGDALDH1A1KDM4EALOX15HTT
SCHEMBL30934954 0.79 MEN1 (0.70) HPGDALDH1A1KDM4EALOX15HTT
SCHEMBL7969979 0.78 MAPT (0.50) SMN1; SMN2MEN1KMT2ACNR2NPC1
SCHEMBL4042951 0.74 PDE5A (0.54) PDE1BHPGDALDH1A1KDM4EALOX15
SCHEMBL19987318 0.72 KDM4E (0.68) KDM4ECNR2NPC1MAPTNLRP3
SCHEMBL12004096 0.72 KDM4E (0.52) KDM4ECNR2TBXA2RCCR2NPC1
SCHEMBL31588700 0.72 TDP1 (0.60) HPGDALDH1A1KDM4EALOX15HTT
SCHEMBL9980488 0.71 PDE1B (0.56) PDE1BHPGDALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019243525-A1 OGA INHIBITOR COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2019-12-26 WO disclosed